While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or ...

Amycretin, a new weight loss drug developed by Novo Nordisk, helped participants lose up to 24.3% of body weight in just 36 ...

A NEW ‘Ozempic pill’ leads to faster weight loss than the popular ‘skinny jabs’, studies have suggested. The new weight loss ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

Novo Nordisk's experimental drug amycretin shows promising results in early trials, aiding significant weight loss in ...

An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight ...

Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...

Novo Nordisk will begin phase 3 trials for amycretin in early 2026 following promising weight loss data and regulatory ...